| 1 | 6103-06-6 | 1,2,4-Oxadiazolidine-3,5-dione, 2-methyl-4-(4-morpholinylmethyl)- | C8H13N3O4 | 215.21 | | |
| 2 | 6103-09-9 | 5,5-BIS(CHLOROMETHYL)-2-PHENYL-1,3-DIOXANE | C12H14Cl2O2 | 261.14 | | |
| 3 | 6103-16-8 | 1,3-Dioxane-5-methanol, 2,5-dimethyl- | C7H14O3 | 146.18 | | |
| 4 | 6103-33-9 | Phenoxathiin, 2-methyl- | C13H10OS | 214.28 | | |
| 5 | 6103-46-4 | 1-(p-Methoxyphenyl)-3-(1-pyrrolidinyl)pyrrolidin-2-one | C15H20N2O2 | 260.33 | | |
| 6 | 6103-50-0 | 3-amino-1-(4-methylphenyl)pyrrolidin-2-one | C11H14N2O | 190.24 | | |
| 7 | 6103-52-2 | 1-(4-Methylphenyl)-3-(1-pyrrolidinyl)pyrrolidin-2-one | C15H20N2O | 244.33 | | |
| 8 | 6103-55-5 | 1-(p-Hydroxyphenyl)-3-piperidinopyrrolidin-2-one | C15H20N2O2 | 260.33 | | |
| 9 | 6103-61-3 | 1-(p-Chlorophenyl)-3-piperidinopyrrolidin-2-one | C15H19ClN2O | 278.78 | | |
| 10 | 6103-64-6 | 2-Pyrrolidinone,3-amino-1-(4-fluorophenyl)-, hydrochloride (1:1) | C14H15Cl3O5 | 369.624 | | |
| 11 | 6103-70-4 | 2-Pyrrolidinone, 3-amino-5-methyl-1-phenyl-, hydrochloride, cis- (8CI) | C11H15ClN2O | 226.7 | | |
| 12 | 6103-81-7 | 2-Pyrrolidinone,5-methyl-3-(methylamino)-1-phenyl-, hydrochloride, trans- (8CI) | C12H17ClN2O | 240.731 | | |
| 13 | 6103-83-9 | 2-Pyrrolidinone, 5-methyl-3-(phenethylamino)-1-phenyl-, monohydrochloride, cis- (8CI) | C19H23ClN2O | 330.86 | | |
| 14 | 6103-98-6 | 2-Pyrrolidinone,3-(benzylamino)-5-methyl-1-phenyl-, trans- (8CI) | C15H21NO | 231.339 | | |
| 15 | 610300-00-0 | β-Amino Acid Imagabalin Hydrochloride (PD-0332334) | C9H20ClNO2 | 209.71 | | |
| 16 | 610300-07-7 | (3S,5R)-3-Amino-5-methyloctanoic acid | C9H19NO2 | 173.25 | | |
| 17 | 610302-00-6 | 2(1H)-Pyrimidinone,tetrahydro-1-(2-hydroxyethyl)-3-methyl-(9CI) | C7H14N2O2 | 158.2 | | |
| 18 | 610302-03-9 | (3-Hydroxy-Cyclohexyl)-Carbamic Acid Tert-Butyl Ester | C11H21NO3 | 215.29 | | |
| 19 | 610303-42-9 | 4-[(3-ethynyl-phenyl)amino]-6-[1-(tert.-butyloxycarbonyl)-piperidin-4-yloxy]-7-methoxy-quinazoline | C27H30N4O4 | 474.55 | | |
| 20 | 610303-43-0 | 4-[(3-ethynyl-phenyl)amino]-6-(tetrahydropyran-4-yloxy)-7-methoxy-quinazoline | C22H21N3O3 | 375.42 | | |
| 21 | 610304-81-9 | (3S,3'S,4S,4'S,11bS,11'bS)-(+)-4,4'-Di-t-butyl-4,4',5,5'-tetrahydro-3,3'-bi-3H-dinaphtho[2,1-c:1',2'-e]phosphepin | C62H48P2 | 734.89 | >300 °C (dec.)(lit.) | |
| 22 | 610305-43-6 | 2-[4-(3,4-Dichloro-benzyl)-morpholin-2-ylmethyl]-isoindole-1,3-dione | C20H18Cl2N2O3 | 405.27 | | |
| 23 | 610307-67-0 | 2,5-Selenophenedicarbonitrile, 3,4-dihydroxy- (9CI) | C6H2N2O2Se | 213.05 | | |
| 24 | 610309-67-6 | N-(2-Hydroxyethyl)(cyclopropylMethyl)aMine Hydrochloride | C6H14ClNO | 151.63446 | | |
| 25 | 610309-73-4 | tert-butyl (2-hydroxyethyl)(isopropyl)carbamate | C10H21NO3 | 203.27864 | | |
| 26 | 610309-77-8 | [(furan-2-yl)methyl](propan-2-yl)amine hydrochloride | C8H14ClNO | 175.65586 | | |
| 27 | 610309-89-2 | Carvedilol phosphate hemihydrate | C24H26N2O4.H2O.H3O4P | 522.488 | | |
| 28 | 610309-90-5 | Cryptdin-4 (Mouse) (0.1 mg vial) | | | | |
| 29 | 61031-72-9 | α,α-Dichlorophenylacetic acid | C8H6Cl2O2 | 205.04 | | |
| 30 | 61031-76-3 | 2,2-Dimethyl-4-oxo-pentanal | C7H12O2 | 128.17 | | |
| 31 | 610311-11-0 | Indeno[1,2-b]pyrrole-2-carboxaldehyde, 1,4-dihydro-3-methyl- (9CI) | C13H11NO | 197.23 | | |
| 32 | 610311-13-2 | Indeno[1,2-b]pyrrole-2-carboxaldehyde, 3-ethyl-1,4-dihydro- (9CI) | C14H13NO | 211.26 | | |
| 33 | 610311-26-7 | 1H-[1]Benzothieno[3,2-b]pyrrole,3-ethyl-(9CI) | C12H11NS | 201.29 | | |
| 34 | 610311-52-9 | Isoxazole, 3-methyl-5-(1H-pyrrol-1-yl)- (9CI) | C8H8N2O | 148.16 | | |
| 35 | 610311-90-5 | 1-Piperazinepropanoic acid, 4-ethyl-2,3-dioxo-, 1,1-dimethylethyl ester | C13H22N2O4 | 270.32 | | |
| 36 | 610311-91-6 | 1-Piperazinepropanoicacid,4-ethyl-2,3-dioxo-(9CI) | C9H14N2O4 | 214.22 | | |
| 37 | 610313-36-5 | 4,4-Bi-1H-imidazole, 2,2-dimethyl-, dihydrate (9CI) | C8H10N4.2H2O | | | |
| 38 | 610313-90-1 | Chol-4-en-24-oic acid, 7-(methoxymethoxy)-3-oxo-, methyl ester, (7α)- | C27H42O5 | 446.62 | | |
| 39 | 610315-36-1 | DIMETHYL 2-ALLYL-2-(2-NITROPHENYL)MALONATE | C14H15NO6 | 293.27 | | |
| 40 | 610315-42-9 | DIMETHYL 2-ALLYL-2-(2,4-DINITROPHENYL)MALONATE | C14H14N2O8 | 338.27 | | |
| 41 | 610315-94-1 | Acetic acid, (3-ethyl-2(3H)-benzothiazolylidene)-, ethyl ester, (2Z)- (9CI) | C13H15NO2S | 249.33 | | |
| 42 | 610316-03-5 | Acetic acid, (3-ethyl-2(3H)-benzothiazolylidene)-, (2Z)- (9CI) | C11H11NO2S | 221.28 | | |
| 43 | 610318-03-1 | RGX-104 | C34H34Cl2F3NO3 | 632.55 | | |
| 44 | 610318-54-2 | RGX-104 free Acid | C34H33ClF3NO3 | 596.08 | | |
| 45 | 61032-13-1 | 2-(4-NITROPHENYL) HYDRAZIDE ETHANEDIOIC ACID MONOETHYL ESTER | C10H11N3O5 | 253.21 | | |
| 46 | 61032-41-5 | Methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate | C16H15NO6 | 317.29 | | |
| 47 | 61032-42-6 | Methyl 2-amino-4-benzyloxy-5-methoxybenzoate | C16H17NO4 | 287.31 | 131-132℃ | |
| 48 | 61032-73-3 | Urea, mixt. with sulfur (1:1) | CH6N2OS | 94.13 | | |
| 49 | 61032-80-2 | Papulacandin B | C47H64O17 | 901 | | |
| 50 | 610322-33-3 | 5-bromo-2-hexoxybenzaldehyde | C13H17BrO2 | 285.17688 | | |
| 51 | 610322-99-1 | Naphthalene, 1,2,3,4-tetrahydro-2-iodo-1-methyl-, (1R,2R)-rel- | C11H13I | 272.13 | | |
| 52 | 610323-25-6 | 2H-BenziMidazol-2-one, 1-[1-[(1R)-1,2-dihydro-1-acenaphthylenyl]-4-piperidinyl]-1,3-dihydro- | C24H23N3O | 369.46 | | |
| 53 | 610323-29-0 | 1H-BenziMidazole-1-acetic acid, 3-[1-[(1R)-1,2-dihydro-1-acenaphthylenyl]-4-piperidinyl]-2,3-dihydro-2-oxo-, ethyl ester | C28H29N3O3 | 455.54816 | | |
| 54 | 610323-32-5 | 1H-BenziMidazole-1-acetaMide, 3-[1-[(1R)-1,2-dihydro-1-acenaphthylenyl]-4-piperidinyl]-2,3-dihydro-N-Methyl-2-oxo- | C27H28N4O2 | 440.53682 | | |
| 55 | 610323-35-8 | 6-FLUORO-1-(PIPERIDIN-4-YL)-1H-BENZO[D]IMIDAZOL-2(3H)-ONE | C12H14FN3O | 235.26 | | |
| 56 | 610323-44-9 | 1-Oxaspiro[2.5]octane,7-methyl-4-(1-methylethyl)-,(3R,4S,7R)-(9CI) | C11H20O | 168.28 | | |
| 57 | 61033-04-3 | 6-Amino-5-nitroso-3-methyluracil | C5H6N4O3 | 170.13 | >350°C | |
| 58 | 61033-06-5 | 1H-Purine-2,6-dione, 3,7-dihydro-7-hydroxy-8-propyl- | C8H10N4O3 | 210.19 | | |
| 59 | 61033-27-0 | [1,2,4]Triazolo[5,1-c][1,2,4]triazine-3-carbonitrile, 4-amino- | C5H3N7 | 161.12 | | |
| 60 | 61033-31-6 | [1,2,4]Triazolo[5,1-c][1,2,4]triazin-7-amine,3,4-diphenyl- | C16H12N6 | 288.31 | | |
| 61 | 61033-37-2 | 5-Hydrazinyl-4H-1,2,4-triazol-3-amine dihydrochloride | C2H8Cl2N6 | 187.03 | | |
| 62 | 61033-69-0 | 1H-IMidazole, 4,5-dihydro-2-(2-cholrophenyl)- | C9H9ClN2 | 180.63 | | |
| 63 | 61033-70-3 | 2-(4-NITROPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE | C9H9N3O2 | 191.19 | | |
| 64 | 61033-71-4 | 4-(4,5-dihydro-1H-imidazol-2-yl)aniline | C9H11N3 | 161.204 | | |
| 65 | 61033-72-5 | 1H-IMidazole, 2-(2,4-dichlorophenyl)-4,5-dihydro- | C9H8Cl2N2 | 215.08 | 98-100 °C | |
| 66 | 61033-86-1 | 4-(4,5-Dihydro-1H-imidazol-2-yl)aniline hydrochloride | C9H12ClN3 | 197.67 | | |
| 67 | 61033-89-4 | 1H-Imidazole, 2,2′-(1,4-phenylene)bis[4,5-dihydro-, dihydrochloride | C12H14N4.2ClH | 287.19 | | |
| 68 | 61034-11-5 | 7-HYDROXY-3-(1-PHENYL-1H-PYRAZOL-4-YL)-CHROMEN-4-ONE | C18H12N2O3 | 304.3 | | |
| 69 | 61034-15-9 | 8-anilino-1,3-dimethyl-7H-purine-2,6-dione | C13H13N5O2 | 271.27 | | |
| 70 | 61034-40-0 | 4-Benzoyl-3,5-dimethyl N-nitrosopiperazine | C13H17N3O2 | 247.29 | | |
| 71 | 61034-86-4 | [2-(1H-PYRROL-1-YL)PHENYL]METHANOL | C11H11NO | 173.21 | 43 °C | |
| 72 | 61035-54-9 | NSC24907 | C8H6Cl5NO | 309.40434 | | |
| 73 | 61035-69-6 | Benzoic acid, 4-[[2-(acetyloxy)-4-methoxy-6-methylbenzoyl]oxy]-2-hydroxy-6-methyl-, 3-hydroxy-4-(methoxycarbonyl)-5-methylphenyl ester | C28H26O11 | 538.5 | | |
| 74 | 61035-74-3 | 1-(4-[(4-CHLOROBENZYL)OXY]PHENYL)ETHANONE | C15H13ClO2 | 260.72 | | |
| 75 | 61035-75-4 | 1-Propanone, 1-[4-[(4-chlorophenyl)methoxy]phenyl]- | C16H15ClO2 | 274.74 | | |
| 76 | 61035-87-8 | 2-[4-(1-methylethyl)phenyl]ethanamine hydrochloride | C11H18ClN | 199.72032 | 167-172 °C | |
| 77 | 61036-24-6 | tetraammonium dipotassium vanadate | H16K2N4O18V6 | 743.98864 | | |
| 78 | 61036-28-0 | Benzoic acid, 2-[2-[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]diazenyl]- | C18H15N5O5 | 381.3422 | | |
| 79 | 61036-45-1 | Papulacandins | C31H42O10 | 574.65918 | | |
| 80 | 61036-46-2 | 1,1-O-(4,6-Dihydroxy-1,2-phenylenemethylene)-4-O-[6-O-(1-oxo-2,4-decadienyl)-β-D-galactopyranosyl]-α-D-glucopyranose 3-(7-hydroxy-8,14-dimethylhexadeca-2,4,8,10-tetraenoate) | C47H66O16 | 887.03 | | |
| 81 | 61036-48-4 | 1,1-O-(4,6-Dihydroxy-1,2-phenylenemethylene)-4-O-[6-O-(8-hydroxy-1-oxodeca-2,4,6-trienyl)-β-D-galactopyranosyl]-α-D-glucopyranose 3-(7-hydroxy-8,14-dimethylhexadeca-2,4,8,10-tetraenoate) | C47H64O17 | 901 | | |
| 82 | 61036-49-5 | Papulacandin D | C31H42O10 | 574.66 | | |
| 83 | 61036-50-8 | Papulacandins E | | | | |
| 84 | 61036-62-2 | Teicoplanin | C78H77Cl2N8O32R | 1709.39 | 310 °C (decomp) | Sparingly soluble in water |
| 85 | 61036-63-3 | teicoplanin A1 | | | | |
| 86 | 61036-64-4 | Teicoplanin A2 | C78H77Cl2N8O32R | 1709.39 | 260° (dec) | |
| 87 | 61036-81-5 | (5R)-3-[[2-(Acetylamino)ethyl]thio]-6α-[(S)-1-(sulfooxy)ethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid disodium salt | C13H16N2Na2O8S2 | 438.38428 | | |
| 88 | 61037-73-8 | poly(tyrosyl-alanyl-glutamyl-glycine) | C19H26N4O8 | 438.43174 | | |
| 89 | 61037-79-4 | phenylalanyl-leucyl-glutamyl-glutamyl-valine | C30H45N5O10 | 635.71 | | |
| 90 | 61037-86-3 | Choline chloride-(trimethyl-d9) | C5H5ClD9NO | 148.68 | 302-305°C (dec.)(lit.) | |
| 91 | 61037-91-0 | Acetamide, 2,2',2'',2'''-[(1-methyl-1,2-ethanediyl)dinitrilo]tetrakis-, (R)- (9CI) | C11H22N6O4 | 302.33 | | |
| 92 | 61037-92-1 | 2,2',2'',2'''-[[(1S)-1-Methyl-1,2-ethanediyl]dinitrilo]tetrakisacetamide | C11H22N6O4 | 302.33018 | | |
| 93 | 61038-31-1 | 10-formyl-5,8-dideazafolate | C22H21N5O7 | 467.43 | | |
| 94 | 61038-32-2 | Pyrido[4,3-d]pyrimidine-2,4-diamine, 5,6,7,8-tetrahydro-6-(phenylmethyl)- | C14H17N5 | 255.32 | | |
| 95 | 61038-42-4 | 2H-1,2,3-Triazolo[4,5-d]pyrimidine,7-(methylthio)-2-b-D-ribofuranosyl- | C10H13N5O4S | 299.30632 | | |
| 96 | 61038-43-5 | b-D-Ribofuranosylamine,N-[1,2,3]thiadiazolo[5,4-d]pyrimidin-7-yl- | C9H11N5O4S | 285.27974 | | |
| 97 | 61038-96-8 | 3-[N,N-Bis(methoxycarbonylethyl)]amino-acetanilide | C16H22N2O5 | 322.36 | | |
| 98 | 61038-97-9 | methyl 4-[[2-(acetylamino)-4-[bis(3-methoxy-3-oxopropyl)amino]phenyl]azo]benzoate | C24H28N4O7 | 484.5 | | |
| 99 | 61039-20-1 | 2-Butanone, 3-(dimethylamino)-4-phenyl- | C12H17NO | 191.27 | | |
| 100 | 61039-29-0 | L-Tyrosine, 3,5-dibroMo-, Methyl ester, hydrochloride (1:1) | C10H12Br2ClNO3 | 389.46818 | | |
| 101 | 61039-45-0 | 1,3-Cyclopentadiene, 5-(1-methylpentylidene)- | C11H16 | 148.24 | | |
| 102 | 61039-46-1 | 1,3-Cyclopentadiene, 5-heptylidene- | C12H18 | 162.27 | | |
| 103 | 61039-47-2 | Cyclohexane, 1-(2,4-cyclopentadien-1-ylidene)-2-methyl- | C12H16 | 160.26 | | |
| 104 | 61039-51-8 | Glycine, N-[2-amino-4-(2-aminophenyl)-1,4-dioxobutyl]- | C12H15N3O4 | 265.27 | | |
| 105 | 61039-99-4 | 1,2-Dioxetane, 4-methoxy-3,3-diphenyl- | C15H14O3 | 242.27 | | |